FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents an agent consisting of theobromine and a non-opiate antitussive agent representing an NMDA antagonist in the form of a combination preparation for treating cough.
EFFECT: invention provides a synergetic effect on cough suppression and improved clinical effectiveness in cough treatment.
20 cl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
DRUG COMBINATION WITH THEOBROMINE AND USE THEREOF IN TREATMENT | 2010 |
|
RU2587329C2 |
ANTIBECHIC COMPOSITION CONTAINING ANTIBECHIC AGENT AND BENZIDAMINE | 1995 |
|
RU2143901C1 |
THEOBROMINE-DECONGESTANT COMBINATION AND APPLICATION THEREOF FOR TREATING COUGH | 2010 |
|
RU2564904C2 |
ANTITUSSIVE | 2009 |
|
RU2427388C2 |
ORALLY ADMINISTRATED LIQUID COMPOSITIONS COMPRISING GUAIFENESIN AND POLYOXYALKYLENE BLOCK-COPOLYMERS | 2002 |
|
RU2281087C2 |
COMPOSITIONS OF NONSTEROID ANTI-INFLAMMATORY DRUGS, ANTICONGESTIVE AGENTS AND ANTIHISTAMINICS | 2003 |
|
RU2322262C2 |
ANALGETIC COMPOSITIONS CONTAINING NON-NARCOTIC ANALGETIC AND ENHANCER OF ANALGESIA | 1995 |
|
RU2213561C2 |
EXTRACT COPTIDIS RHIZOMA AND ITS USE IN TREATING RESPIRATORY DISEASE | 2009 |
|
RU2461388C1 |
COMPOSITIONS AND METHODS ASSOCIATED THEREWITH | 2017 |
|
RU2764716C2 |
LIQUID COMPOSITIONS OF PHENYLEPHRINE WITH INCREASED STABILITY | 2007 |
|
RU2468787C2 |
Authors
Dates
2014-06-10—Published
2010-11-12—Filed